Teva Pharmaceutical Industries (TEVA)
Add to Watchlists Create an Alert
39.34
-0.15 -0.38%
NYSE
May 24, 8:00PM
BATS Real time
Currency in USD
Teva Pharmaceutical Industries Revenue Quarterly YoY Growth:
-3.94% for March 31, 2013Teva Pharmaceutical Industries Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -3.94% |
| Dec. 31, 2012 | -7.52% |
| Sept. 30, 2012 | 14.46% |
| June 30, 2012 | 18.57% |
| March 31, 2012 | 25.05% |
| Dec. 31, 2011 | 28.47% |
| Sept. 30, 2011 | 2.21% |
| June 30, 2011 | 10.84% |
| March 31, 2011 | 11.69% |
| Dec. 31, 2010 | 16.20% |
| Sept. 30, 2010 | 19.72% |
| June 30, 2010 | 11.76% |
| March 31, 2010 | 16.08% |
| Dec. 31, 2009 | 33.50% |
| Sept. 30, 2009 | 24.91% |
| June 30, 2009 | 20.44% |
| March 31, 2009 | 22.36% |
| Dec. 31, 2008 | 10.56% |
| Sept. 30, 2008 | 20.12% |
| June 30, 2008 | 18.32% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
TEVA Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Pfizer | -9.30% |
| Mylan | 3.02% |
| Alexza Pharmaceuticals | -61.31% |
TEVA Revenue Quarterly YoY Growth Rankings
| Overall |
53rd percentile 3565 of 7600 |
| Sector |
44th percentile 364 of 653 in Healthcare |
| Industry |
45th percentile 36 of 66 in Drug Manufacturers - Specialty & Generic |
TEVA Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -7.52% | Dec 2012 |
| Maximum | 33.50% | Dec 2009 |
| Average | 15.69% |
